Company Filing History:
Years Active: 2003
Title: Innovations by Rachel R Wallace-Brodeur
Introduction
Rachel R Wallace-Brodeur is an accomplished inventor based in Huntington Station, NY (US). He has made significant contributions to the field of biomedical research, particularly in the study of lymphomas. His innovative work has led to the development of valuable tools for understanding cancer and testing potential treatments.
Latest Patents
Rachel holds a patent for "Lymphoma-susceptible transgenic mice and methods for studying drug sensitivity of lymphomas." This invention involves a mouse model that expresses myc in B cells due to the defective function of one or more tumor suppressor genes. These mice are instrumental in testing anti-lymphoma agents and studying genes that may influence the apoptotic pathway. The preferred embodiments of this invention include specific genotypes such as E&mgr;-myc/p53, E&mgr;-myc/Rb, and E&mgr;-myc/p16. The invention also encompasses mouse strains, lymphoma cells, and cell lines that can be utilized to discover new anti-lymphoma agents and characterize tumors.
Career Highlights
Rachel is affiliated with Cold Spring Harbor Laboratory, where he conducts his research. His work has been pivotal in advancing the understanding of lymphoma and developing new therapeutic strategies. He has a strong focus on the genetic factors that contribute to cancer resistance and sensitivity.
Collaborations
Rachel collaborates with notable researchers in his field, including Scott William Lowe. Their joint efforts aim to enhance the understanding of cancer biology and improve treatment options for patients.
Conclusion
Rachel R Wallace-Brodeur's innovative contributions to cancer research, particularly through his patented mouse model, have the potential to significantly impact the development of new therapies for lymphoma. His work exemplifies the importance of innovation in the fight against cancer.